Literature DB >> 2880296

Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome.

J Kere, T Ruutu, A de la Chapelle.   

Abstract

Monosomy for all or part of chromosome 7 in bone marrow mitoses of some patients with myelodysplastic syndrome or acute nonlymphocytic leukemia has been associated with a defect in granulocyte function. To study which blood-cell lineages are affected by the monosomy, we used chromosome 7-specific DNA probes in Southern blotting experiments on DNA derived from specific cell fractions isolated from the blood of five patients. As judged by the presence or absence of two different alleles for restriction-fragment-length polymorphisms, lymphocytes of all five patients were shown to have two different chromosomes 7. Granulocytes were affected by the chromosomal abnormality in four patients (No. 1, 2, 4, and 5) and unaffected in one (No. 3). Chemotaxis was normal in Patient 3 and impaired in Patients 4 and 5. Monocytes were affected by the monosomy in two of three patients (No. 2 and 3) and mainly unaffected in one (No. 1). Thus, the granulocytes and monocytes were affected differently in different patients. We conclude that mature blood cells are derived from abnormal progenitors and that there may be heterogeneity in the involvement of different cell lineages in different patients with myelodysplastic syndrome or acute nonlymphocytic leukemia. There is an association between DNA loss and functional impairment.

Entities:  

Mesh:

Year:  1987        PMID: 2880296     DOI: 10.1056/NEJM198702263160902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  7q-and loss of a polymorphism for the met oncogene in a patient with myelofibrosis.

Authors:  G Rege-Cambrin; A Guerrasio; A Serra; A Alfarano; A Stacchini; P Lusso; G Benetton; M Aglietta; M Bonetto; G Saglio
Journal:  Cytotechnology       Date:  1987-10       Impact factor: 2.058

2.  Regional assignment of 41 human DNA fragments on chromosome 7 by means of a somatic cell hybrid panel.

Authors:  A Jobs; D Klein-Bölting; A S Jandel; A Driesel; K Olek; K H Grzeschik
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

3.  Mortality from leukaemia among relatives of patients with cystic fibrosis.

Authors:  L N al-Jader; R R West; M C Goodchild; P S Harper
Journal:  BMJ       Date:  1989-01-21

4.  Assessment of DNA content and cell cycle distribution of erythroid and myeloid cells from bone marrow.

Authors:  J Hodgetts; T G Hoy; A Jacobs
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

5.  Isolation of a polymorphic genomic clone from chromosome 7. Physical and genetic linkage studies to markers around the cystic fibrosis locus.

Authors:  K A Davies; L Lorand; M Waterfield; B Wainwright; M Farrall; R Williamson
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

Review 6.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

7.  Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.

Authors:  K M Shannon; A G Turhan; S S Chang; A M Bowcock; P C Rogers; W L Carroll; M J Cowan; B E Glader; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

8.  Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe.

Authors:  J Anastasi; M M Le Beau; J W Vardiman; C A Westbrook
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

9.  Lymph node disease with lymphocytic abnormal chromatin clumping in a myelodysplastic/myeloproliferative syndrome.

Authors:  J Gardais
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

10.  Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.

Authors:  J Boultwood; K Rack; S Kelly; J Madden; A Y Sakaguchi; L M Wang; D G Oscier; V J Buckle; J S Wainscoat
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.